Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 4 for:    buspirone | "Autistic Disorder"
Previous Study | Return to List | Next Study

Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder (B-ACE)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Diane C Chugani, Wayne State University
ClinicalTrials.gov Identifier:
NCT00873509
First received: March 30, 2009
Last updated: October 4, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)